| With valid data | All/BP | IS/lipids | ICH |
---|---|---|---|---|
Number | 83 | 83 | 77 | 6 |
Age (years) + | 83 | 74.0 (6.8) | 74.3 (6.6) | 70.8 (8.4) |
 >75 (%) | 83 | 42 (50.6) | 39 (50.6) | 3 (50.0) |
Sex, male (%) + | 83 | 64 (77.1) | 61 (79.2) | 3 (50) |
Time to randomisation [months] + | 83 | 4.5 [1.3] | 4.5 [1.2] | 3.8 [1.7] |
 <4 (%) | 83 | 21 (25.3) | 17 (22.1) | 4 (66.7) |
Medical history (%) | Â | Â | Â | Â |
 Memory problem | 77 | 34 (44.2) | 30 (42.3) | 4 (66.7) |
 If yes, length (months) | 34 | 4.8 (2.7) | 4.9 (2.9) | 4.3 (1.5) |
Depression, recent | 83 | 4 (4.8) | 4 (5.2) | 0 (0.0) |
Hypertension, treated | Â | Â | Â | Â |
 Pre-index stroke | 83 | 51 (61.4) | 47 (61.0) | 4 (66.7) |
 Post-index stroke | 83 | 18 (21.7) | 16 (20.8) | 2 (33.3) |
 Neither | 83 | 14 (16.9) | 14 (18.2) | 0 (0.0) |
Hypertension treated with | Â | Â | Â | Â |
 Life style measures only | 69 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
 Medications only | 69 | 36 (52.2) | 34 (54.0) | 2 (33.3) |
 Both | 69 | 30 (43.5) | 26 (41.3) | 4 (66.7) |
 Neither | 69 | 3 (4.3) | 3 (4.8) | 0 (0.0) |
Hyperlipidaemia | 83 | 73 (88.0) | 68 (88.3) | 5 (83.3) |
 Life style measures only | 73 | 1 (1.4) | 0 (0.0) | 1 (20.0) |
 Medications only | 73 | 46 (63.0) | 44 (64.7) | 2 (40.0) |
 Both | 73 | 24 (32.9) | 22 (32.4) | 2 (40.0) |
 Neither | 73 | 2 (2.7) | 2 (2.9) | 0 (0.0) |
Diabetes mellitus | 83 | 17 (20.5) | 16 (20.8) | 1 (16.7) |
Atrial fibrillation | 83 | 15 (18.1) | 15 (19.5) | 0 (0.0) |
Stroke | 83 | 8 (9.6) | 8 (10.4) | 0 (0.0) |
Transient ischaemic attack | 83 | 16 (19.3) | 15 (19.5) | 1 (16.7) |
Ischaemic heart disease | 83 | 20 (24.1) | 19 (24.7) | 1 (16.7) |
Myocardial infarction | 83 | 11 (13.3) | 11 (14.3) | 0 (0.0) |
Angina | 83 | 18 (21.7) | 17 (22.1) | 1 (16.7) |
Peripheral artery disease | 83 | 5 (6.0) | 5 (6.5) | 0 (0.0) |
Young stroke in first degree | 83 | 10 (12.0) | 10 (13.0) | 0 (0.0) |
Relative smoking (%) | Â | Â | Â | Â |
 Current | 83 | 5 (6.0) | 5 (6.5) | 0 (0.0) |
 Past | 83 | 51 (61.4) | 48 (62.3) | 3 (50.0) |
 Never | 83 | 27 (32.5) | 24 (31.2) | 3 (50.0) |
Alcohol (%) | Â | Â | Â | Â |
 >21 | 83 | 3 (3.6) | 3 (3.9) | 0 (0.0) |
 <21 | 83 | 56 (67.5) | 52 (67.5) | 4 (66.7) |
 None | 83 | 24 (28.9) | 22 (28.6) | 2 (33.3) |
Median [upw] | 83 | 3 [0, 10] | 4 [0, 10] | 1 [0, 1] |
BP tablets (%) + | Â | Â | Â | Â |
 0 | 83 | 14 (16.9) | 14 (18.2) | 0 (0.0) |
 1 | 83 | 28 (33.7) | 25 (32.5) | 3 (50.0) |
 2 | 83 | 29 (34.9) | 28 (36.4) | 1 (16.7) |
 3 | 83 | 11 (13.3) | 9 (11.7) | 2 (33.3) |
 > = 4 | 83 | 1 (1.2) | 1 (1.3) | 0 (0.0) |
Median [IQR] | 83 | 1 [1, 2] | 1 [1, 2] | 1.5 [1, 3] |
Lipid tablets (%) | Â | Â | Â | Â |
 Any statin + | 83 | 79 (95.2) | 75 (97.4) | 4 (66.7) |
 Atorvastatin | 79 | 21 (26.6) | 19 (25.3) | 2 (50.0) |
 Fluvastatin | 79 | 1 (1.3) | 1 (1.3) | 0 (0.0) |
 Rosuvastatin | 79 | 2 (2.5) | 2 (2.7) | 0 (0.0) |
 Simvastatin | 79 | 55 (69.6) | 53 (70.7) | 2 (50.0) |
Pre-morbid mRS (%) + mRS 0 | 83 | 20 (24.1) | 18 (23.4) | 2 (33.3) |
mRS 1 | 83 | 40 (48.2) | 37 (48.1) | 3 (50.0) |
 mRS 2 | 83 | 19 (22.9) | 18 (23.4) | 1 (16.7) |
 mRS > 2 ^ | 83 | 4 (4.8) | 4 (5.2) | 0 (0.0) |
 Mean (SD) | 83 | 1.08 (0.8) | 1.10 (0.8) | 0.83 (0.8) |
Hand dominance (%) Right | 83 | 76 (91.6) | 70 (90.9) | 6 (100.0) |
 Left | 83 | 6 (7.2) | 6 (7.8) | 0 (0.0) |
 Both | 83 | 1 (1.2) | 1 (1.3) | 0 (0.0) |
Side of weakness, left (%) | 63 | 32 (50.8) | 30 (50.0) | 2 (66.7) |
NIHSS (%) Mean (SD) + | 83 | 0.77 (1.1) | 0.78 (1.1) | 0.67 (0.8) |
 Median [IQR] | 83 | 0 [0,1] | 0 [0,1] | 0.5 [0,1] |
OCSP classification (%) Total anterior + | 83 | 6 (7.2) | 6 (7.8) | 0 (0.0) |
 Partial anterior | 83 | 36 (43.4) | 32 (41.6) | 4 (66.7) |
 Lacunar | 83 | 34 (41.0) | 32 (41.6) | 2 (33.3) |
 Posterior | 83 | 7 (8.4) | 7 (9.1) | 0 (0.0) |
Addenbrooke's Cognitive Exam-R + | 83 | 86.1 (7.7) | 86.0 (7.6) | 87.5 (9.9) |
MMSE | 83 | 27.9 (2.0) | 27.9 (1.9) | 27.7 (2.7) |
Telephone MMSE | 83 | 20.4 (1.8) | 20.4 (1.7) | 20.3 (2.7) |
Montreal Cognitive Assessment | 83 | 24.0 (2.6) | 24.1 (2.6) | 22.7 (2.5) |
TICS-M | 83 | 24.1 (4.2) | 24.3 (4.2) | 22.2 (2.6) |
Stroop: Part 1 time (sec) | 83 | 54.7 | 54.6 (20.5) | 55.5 (23.6) |
Stroop: Part 1 score | 83 | (20.6) 0.97 (0.0) | 0.97 (0.0) | 0.99 (0.0) |
Stroop: Part 2 time (sec) | 83 | 46.1 | 46.0 (19.9) | 46.6 (31.5) |
Stroop: Part 2 score | 83 | (20.7) 0.97 (0.0) | 0.97 (0.0) | 0.96 (0.1) |
Stroop: Part 3 time (sec) | 83 | 66.9 | 67.3 (34.8) | 62.2 (32.9) |
Stroop: Part 3 score | 83 | (34.5) 0.83 (0.2) | 0.83 (0.2) | 0.79 (0.3) |
Stroop: Interference time (Parts 3-2) (sec) | 83 | 20.9 | 21.3 (22.3) | 15.6 (21.2) |
Stroop - Interference score (Parts 32) | 83 | (22.1) -0.14 (0.2) | -0.14 (0.2) | -0.17 (0.3) |
Trail making A time (sec) | 83 | 57.1 | 58.1 (30.7) | 43.7 (12.0) |
Trail making A score | 83 | (30.0) 24.6 (2.8) | 24.6 (2.9) | 25.0 (0.0) |
Trail making B time (sec) | 83 | 155.5 | 151.5 | 207.2 |
Trail making B score | 83 | (90.8) 22.1 (5.5) | (78.9) 21.9 (5.7) | (192.6) 24.8 (0.4) |
IQCODE (from informant) | 83 | 3.0 (0.5) | 3.0 (0.5) | 3.2 (0.2) |
Systolic BP (mmHg) + | 83 | 147.1 | 147.7 | 139.8 |
 <140 (%) | 83 | (18.6) 32 (38.6) | (18.6) 30 (39.0) | (18.3) 2 (33.3) |
 <125 (%) | 83 | 9 (10.8) | 8 (10.4) | 1 (16.7) |
Diastolic BP (mmHg) | 83 | 82.1 (11.1) | 82.3 (11.1) | 80.1 (13.1) |
Heart rate (bpm) | 83 | 71.5 (14.2) | 71.7 (14.1) | 69.5 (16.7) |
Lipids (mmol/L) | Â | Â | Â | Â |
Total cholesterol + | 83 | 4.0 (0.8) | 4.0 (0.8) | 4.3 (1.2) |
 Triglycerides | 82 | 1.3 (0.6) | 1.3 (0.6) | 1.6 (0.6) |
 HDL cholesterol | 81 | 1.4 (0.5) | 1.4 (0.5) | 1.5 (0.5) |
 LDL cholesterol | 80 | 2.0 (0.7) | 2.0 (0.7) | 1.9 (1) |
 Non-HDL cholesterol | 81 | 2.6 (0.8) | 2.6 (0.8) | 2.8 (0.8) |
Estimated GFR (ml/min) | 79 | 67.5 (11.6) | 68.0 (11.3) | 60.8 (13.7) |
Glucose (mmol/L) | 77 | 5.6 (1.6) | 5.6 (1.6) | 5.7 (2.0) |